Emerald Medical Applications Corp. - Statements of Operations	3 Months Ended		9 Months Ended
	Sep. 30, 2016 USD ($) $ / shares shares	Sep. 30, 2015 USD ($) $ / shares shares	Sep. 30, 2016 USD ($) $ / shares shares	Sep. 30, 2015 USD ($) $ / shares shares
Statements of Operations
Revenue	$ 0	$ 0	$ 0	$ 0
Expenses:
Research and developement expenses	(155,338)	(252,498)	(450,688)	(499,898)
Stock-based compensation	(371,715)	(5,343,088)	(2,766,823)	(5,343,088)
General and administrative expenses	(206,222)	(983,329)	(579,850)	(1,157,720)
Total operating expenses	(733,275)	(6,578,915)	(3,797,361)	(7,000,706)
(Loss) from operations	(733,275)	(6,578,915)	(3,797,361)	(7,000,706)
Other income (expense):
Change in fair value of derivative	0	20,165	0	20,532
Amortization of debt discount	(160,050)	0	(211,715)	0
Other income (expenses)	186,615	0	215,202	0
Gain/loss from foreign currency	31,339	(6,934)	30,299	(16,955)
Loss on settlement of debt	$ 0	$ (678,027)	$ 0	$ (678,027)
Other income (expense)	57,904	(664,796)	33,786	(674,450)
Total income (expense)	(675,371)	(7,243,711)	(3,763,575)	(7,675,156)
Provision for income taxes	0	0	0	0
Net (loss)	$ (675,371)	$ (7,243,711)	$ (3,763,575)	$ (7,675,156)
Basic and diluted net loss per share | $ / shares	$ (0.03)	$ (0.54)	$ (0.20)	$ (0.81)
Weighted average shares outstanding
Basic and diluted | shares	19,795,343	13,413,006	18,659,674	9,451,649